Gut Transit Time Study Links Digestive Speed to Health Outcomes
By
mikhael
A five-star bake. Worth schmearing, sharing, saving.
Summary
A 2023 review combining data from dozens of studies found that gut transit time - how quickly or slowly food moves through the digestive system - has significant implications for health. The research reveals distinct differences between the gut microbiomes of 'speeders' (fast transit) and 'slowpokes' (slow transit), with slow transit times and constipation being linked to metabolic and inflammatory disorders. The study suggests that transit time may be an important but previously overlooked factor in gut health and overall wellbeing.
Key quotes
· 4 pulledWhether poop speeds through your gut like a bullet train or takes a more smell-the-roses approach could have more profound implications for your overall health than a first glance would suggest.
According to a 2023 review that combined data from dozens of studies, distinct differences can be observed between the gut microbiomes of 'speeders' and 'slowpokes'.
Since the human gut microbiome is intrinsically linked to health, this could have implications that have gone unnoticed before now.
In particular, slow transit times and constipation have been linked with metabolic and inflammatory disorders.
You might also wanna read
Exploring the science behind quantum effects in healthcare: separating research from pseudoscience
The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
Experimental pill daraxonrasib extends survival in advanced pancreatic cancer patients, study finds
Researchers reported that daraxonrasib, a novel experimental pill, helped patients with advanced pancreatic cancer live longer by blocking a
GeneSkin Develops mRNA Therapy Targeting Skin Stem Cells for Rejuvenation and Hair Growth
GeneSkin is developing a novel mRNA therapy targeting basal stem cells in the skin to address a wide range of dermatological issues includin
First human trial begins for drug that could regrow missing teeth
Kyoto University Hospital has launched the first human trial of TRG-035, a drug designed to regrow teeth in adults by blocking a protein tha
